Oxidative stress induces ferroptotic cell death in retinal pigment epithelial cells. 2019

Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
Department of Ophthalmology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan. Electronic address: kiyototsuka916@gmail.com.

The dysfunction and cell death of retinal pigment epithelial (RPE) cells are hallmarks of late-stage dry (atrophic) age-related macular degeneration (AMD), for which no effective therapy has yet been developed. Previous studies have indicated that iron accumulation is a source of excess free radical production in RPE, and age-dependent iron accumulation in RPE is accelerated in patients with dry AMD. Although the pathogenic role of oxidative stress in RPE in the development of dry AMD is widely accepted, the mechanisms of oxidative stress-induced RPE cell death remain elusive. Here, we show that ferroptotic cell death, a mode of regulated necrosis mediated by iron and lipid peroxidation, is implicated in oxidative stress-induced RPE cell death in vitro. In ARPE-19 cells we observed that the ferroptosis inhibitors ferrostatin-1 and deferoxamine (DFO) rescued tert-butyl hydroperoxide (tBH)-induced RPE cell death more effectively than inhibitors of apoptosis or necroptosis. tBH-induced RPE cell death was accompanied by the three characteristics of ferroptotic cell death: lipid peroxidation, glutathione depletion, and ferrous iron accumulation, which were all significantly attenuated by ferrostatin-1 and DFO. Exogenous iron overload enhanced tBH-induced RPE cell death, but this effect was also attenuated by ferrostatin-1 and DFO. Furthermore, mRNA levels of numerous genes known to regulate iron metabolism were observed to be influenced by oxidative stress. Taken together, our observations suggest that multiple modes of cell death are involved in oxidative stress-induced RPE cell death, with ferroptosis playing a particularly important role.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008268 Macular Degeneration Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms. Maculopathy,Maculopathy, Age-Related,Age-Related Macular Degeneration,Age-Related Maculopathies,Age-Related Maculopathy,Macular Degeneration, Age-Related,Macular Dystrophy,Maculopathies, Age-Related,Age Related Macular Degeneration,Age Related Maculopathies,Age Related Maculopathy,Age-Related Macular Degenerations,Degeneration, Macular,Dystrophy, Macular,Macular Degeneration, Age Related,Macular Degenerations,Macular Dystrophies,Maculopathies,Maculopathy, Age Related
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000079403 Ferroptosis A form of REGULATED CELL DEATH initiated by oxidative perturbations of the intracellular microenvironment that is under constitutive control by glutathione peroxidase 4 and can be inhibited by iron chelators and lipophilic antioxidants. Oxytosis
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen

Related Publications

Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
December 2013, Cell death & disease,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
April 2020, Toxicology letters,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
September 2023, Scientific reports,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
July 2006, Investigative ophthalmology & visual science,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
January 2013, PloS one,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
January 2008, Experimental eye research,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
July 2023, Disease models & mechanisms,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
February 2009, Investigative ophthalmology & visual science,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
March 2014, Free radical research,
Kiyohito Totsuka, and Takashi Ueta, and Takatoshi Uchida, and Murilo F Roggia, and Suguru Nakagawa, and Demetrios G Vavvas, and Megumi Honjo, and Makoto Aihara
May 2008, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
Copied contents to your clipboard!